UIA
BIOA

Ulland Investment Advisors’s BioAge Labs BIOA Stock Holding History

Ulland Investment Advisors’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20
Closed – – 224
2025
Q4 		$0 Hold
20
– – ﹤0.01% 232
2025
Q3 		$0 Hold
20
– – ﹤0.01% 243
2025
Q2 		$0 Hold
20
– – ﹤0.01% 234
2025
Q1 		$0 Hold
20
– – ﹤0.01% 229
2024
Q4 		$0 Buy
+20
New +$345 ﹤0.01% 218

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Ulland Investment Advisors's BIOA Position: Q1 2026 in Review

Ulland Investment Advisors sold out of BioAge Labs (BIOA) in Q1 2026, closing a stake of 20 shares.

Ulland Investment Advisors first reported a position in BIOA in Q4 2024 and held it in 5 quarters. The position peaked at $0 in Q4 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Ulland Investment Advisors reported no remaining BioAge Labs position as of Q1 2026 after selling out during the quarter.
  • Ulland Investment Advisors sold 20 BioAge Labs shares in Q1 2026.
  • Ulland Investment Advisors first reported a position in BioAge Labs in Q4 2024 and held it in 5 quarters.
  • Ulland Investment Advisors's BioAge Labs position peaked at $0 in Q4 2025.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Ulland Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.